Ventyx Biosciences Ownership | Who Owns Ventyx Biosciences?


OverviewForecastRevenueFinancialsChartTranscripts

Ventyx Biosciences Ownership Summary


Ventyx Biosciences is owned by 92.10% institutional investors, 3.31% insiders, and 4.59% retail investors. Deerfield management company, l.p. (series c) is the largest institutional shareholder, holding 9.43% of VTYX shares. American Funds SMALLCAP World A is the top mutual fund, with 7.43% of its assets in Ventyx Biosciences shares.

VTYX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVentyx Biosciences92.10%3.31%4.59%
SectorHealthcare Stocks 47.38%7.99%44.63%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Deerfield management company, l.p. (series c)5.83M9.43%$13.47M
Blackrock4.77M7.72%$11.02M
Farallon capital management3.17M5.13%$7.32M
Tang capital management3.10M5.01%$7.16M
Vanguard group2.99M4.84%$6.92M
Octagon capital advisors lp2.39M3.87%$5.52M
Redmile group2.16M3.50%$5.00M
Goldman sachs group1.46M2.36%$3.37M
Vestal point capital, lp1.31M2.13%$3.04M
Geode capital management1.31M2.13%$3.04M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Qiming u.s. ventures management412.23K1.81%$952.24K
Octagon capital advisors lp2.39M0.87%$5.52M
Tang capital management3.10M0.73%$7.16M
Sio capital management778.92K0.49%$1.80M
Sphera funds management1.01M0.32%$2.34M
Redmile group2.16M0.30%$5.00M
Wexford capital lp449.05K0.26%$1.04M
Vestal point capital, lp1.31M0.23%$3.04M
Deerfield management company, l.p. (series c)5.83M0.22%$13.47M
Ikarian capital442.65K0.18%$1.02M

Top Buyers

HolderShares% AssetsChange
Deerfield management company, l.p. (series c)5.83M0.22%2.29M
Vestal point capital, lp1.31M0.23%1.31M
Blackrock4.77M0.00%1.02M
Octagon capital advisors lp2.39M0.87%890.00K
Jacobs levy equity management475.73K0.00%475.73K

Top Sellers

HolderShares% AssetsChange
Capital investors---5.25M
Cormorant asset management, lp---2.71M
Point72 asset management---2.53M
Orbimed advisors---1.87M
Adage capital partners gp---1.27M

New Positions

HolderShares% AssetsChangeValue
Vestal point capital, lp1.31M0.23%1.31M$3.04M
Jacobs levy equity management475.73K0.00%475.73K$1.10M
Acadian asset management263.56K0.00%263.56K$608.00K
Point72 (difc)66.61K0.01%66.61K$153.88K
Aqr capital management56.55K0.00%56.55K$130.63K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-9.00
Zurcher kantonalbank (zurich cantonalbank)-55.00
Avion wealth-63.00
Riggs asset managment-171.00
Daiwa securities group-228.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024118-9.23%56,948,301-3.20%920.93%56-26.32%36-5.26%
Mar 31, 20241304.00%58,833,41036.04%991.85%76-3815.15%
Dec 31, 2023125-17.22%43,247,835-20.76%730.85%761.33%33-28.26%
Sep 30, 2023151-5.63%54,581,5133.40%931.11%75-25.74%4643.75%
Jun 30, 20231604.58%52,789,1126.11%911.23%10117.44%32-27.27%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A5.25M7.43%2.89M
Vanguard Total Stock Mkt Idx Inv1.78M2.52%-
iShares Russell 2000 ETF1.58M2.23%-3.54K
Vanguard Institutional Extnd Mkt Idx Tr800.15K1.13%-
Fidelity Small Cap Index620.84K0.88%-12.43K
iShares Russell 2000 Value ETF568.64K0.80%-
Delaware Healthcare I430.00K0.61%-
State St Russell Sm/Mid Cp® Indx NL Cl C425.78K0.60%-12.50K
iShares Biotechnology ETF376.30K0.53%-2.25K
Fidelity Extended Market Index352.30K0.50%18.02K

Recent Insider Transactions


DateNameRoleActivityValue
Apr 02, 2024Krueger Christopher W CHIEF BUSINESS OFFICERSell$8.92K
Apr 02, 2024Nuss John CHIEF SCIENTIFIC OFFICERSell$8.92K
Apr 02, 2024Mohan Raju CEO AND PRESIDENTSell$23.30K
Apr 02, 2024Auster Martin CHIEF FINANCIAL OFFICERSell$7.59K
Dec 20, 2023Nuss John Chief Scientific OfficerSell$37.33K

Insider Transactions Trends


DateBuySell
2024 Q3--
2024 Q2-4
2024 Q1--
2023 Q4-10
2023 Q3-73

VTYX Ownership FAQ


Who Owns Ventyx Biosciences?

Ventyx Biosciences shareholders are primarily institutional investors at 92.10%, followed by 3.31% insiders and 4.59% retail investors. The average institutional ownership in Ventyx Biosciences's industry, Biotech Stocks , is 45.43%, which Ventyx Biosciences exceeds.

Who owns the most shares of Ventyx Biosciences?

Ventyx Biosciences’s largest shareholders are Deerfield management company, l.p. (series c) (5.83M shares, 9.43%), Blackrock (4.77M shares, 7.72%), and Farallon capital management (3.17M shares, 5.13%). Together, they hold 22.27% of Ventyx Biosciences’s total shares outstanding.

Does Blackrock own Ventyx Biosciences?

Yes, BlackRock owns 7.72% of Ventyx Biosciences, totaling 4.77M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.02M$. In the last quarter, BlackRock increased its holdings by 1.02M shares, a 27.34% change.

Who is Ventyx Biosciences’s biggest shareholder by percentage of total assets invested?

Qiming u.s. ventures management is Ventyx Biosciences’s biggest shareholder by percentage of total assets invested, with 1.81% of its assets in 412.22K Ventyx Biosciences shares, valued at 952.24K$.

Who is the top mutual fund holder of Ventyx Biosciences shares?

American Funds SMALLCAP World A is the top mutual fund holder of Ventyx Biosciences shares, with 7.43% of its total shares outstanding invested in 5.25M Ventyx Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools